To the editor — An epidemic can open a window of opportunity for reflection on and a revolution in disease control and prevention. In China, the 2003 severe acute respiratory syndrome (SARS) epidemic urged the national paper-based disease-reporting system to be transformed into the national notifiable disease reporting system (NNDRS), a system operated by the Chinese Center for Disease Control and Prevention (CDC) to facilitate the complete and timely reporting of cases of infectious disease. The coronavirus disease 2019 (COVID-19) pandemic is now posing an urgent call for upgrading the NNDRS further.
With the paper-based disease-reporting system that had been used in China before 2004, district-level (or county-level) aggregated cases were reported laboriously by mail through the municipal (or prefectural) CDC, the provincial CDC and, finally, the national CDC. Because of the SARS outbreak, the operational mechanism of the paper-based system had been updated for more responsiveness, toward the web-based NNDRS, with which individual cases from every hospital, township and upper-level primary healthcare clinic are reported directly to the national CDC. Before the outbreak of COVID-19, the NNDRS had been monitoring the progress of 39 infectious diseases, identified in the Law on the Prevention and Control of Infectious Diseases of China.
The average time between the identification of a disease case and reporting of that case to the Chinese CDC has been shortened from 29 days to under 2 hours for all Category A and specified Category B infectious diseases, or 24 hours for all unspecified Category B infectious diseases. On 20 January 2020, COVID-19 was officially defined as a Category B infectious disease but was reported as a Category A infectious disease within 2 hours. Nevertheless, it may still take time for different levels of the CDC to confirm the suspected cases.
Spatial life course epidemiology1—the study of evolving agents, mobile hosts and changing environments as a dynamic epidemiological triad2—could upgrade the current NNDRS into a national intelligent syndromic surveillance system (NISSS), with which early risk could be identified on the basis of information about patients’ symptoms (e.g., cough, fever, diarrhea, vomiting and shortness of breath) during the early phases of illness, sometimes with the assistance of surrogate data that indicate early illness (e.g., school or work absenteeism data, or veterinary data such as unexpected avian deaths)3. Going beyond traditional epidemiology, spatial life course epidemiology utilizes an array of advanced technologies, including artificial intelligence, to support both data analysis and decision making and to automate the analysis of risk factors, transmission patterns and potential measures that could be used to control the spread of the disease, which could dramatically improve the public health response4,5.
For this system to work at its best capacity, information input from end users, such as from doctors, hospital information systems, citizens, medical literature databases and internet activities, and other external sources is required and enabled by the current technology (Fig. 1). The NISSS could also field duplicate reporting and reporting inconsistency from different sources.
The protection of individual privacy rights should be paramount in the NISSS, which can be fully realized in the era of technology. A careful protocol must thus be discussed thoroughly among multiple information providers; this should include solving several key issues, such as the following: suspected cases or places reported and/or positioned by individuals (e.g., doctors or citizens) should be made anonymous and should be available only to certain groups before confirmation; individuals posting suspected cases or places should be made anonymous and should be identifiable only by certain groups; actual locations of confirmed cases may be made anonymous and/or offset toward a random direction by a certain distance before being shown in the NISSS; and the information on confirmed cases should be, to different degrees, available to various groups6.
The CDC will be made more intelligent in detecting early risk so that three key lessons from the SARS outbreak could be better taken: honesty is needed; controversy can lead to lost chances; and conclusions may be premature7. The NISSS will enable coordinated data-sharing mechanisms ahead of an outbreak, improving the reporting, quality and accessibility of data in an era of high-impact and high-frequency epidemics8.
Change history
18 June 2020
A Correction to this paper has been published: https://doi.org/10.1038/s41591-020-0977-2
References
Jia, P. Lancet Planet Health 3, e57–e59 (2019).
Jia, P. et al. Trends Parasitol. 36, 235–238 (2020).
Henning, K. J. MMWR Suppl. 53, 5–11 (2004).
Jia, P. et al. Environ. Health Perspect. 127, 74501 (2019).
Jia, P. et al. Health Place 61, 102243 (2020).
Jia, P. Front. Public Health 6, 236 (2018).
Zhong, N. & Zeng, G. Br. Med. J 333, 389–391 (2006).
Jia, P. & Yang, S. Nature 580, 321 (2020).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Jia, P., Yang, S. China needs a national intelligent syndromic surveillance system. Nat Med 26, 990 (2020). https://doi.org/10.1038/s41591-020-0921-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-020-0921-5
This article is cited by
-
Limitations of COVID-19 testing and case data for evidence-informed health policy and practice
Health Research Policy and Systems (2023)
-
Pandemetrics: systematically assessing, monitoring, and controlling the evolution of a pandemic
Quality & Quantity (2023)
-
An extended Weight Kernel Density Estimation model forecasts COVID-19 onset risk and identifies spatiotemporal variations of lockdown effects in China
Communications Biology (2021)
-
Cross-disciplinary approaches to assist with nucleic acid testing for SARS-CoV-2
Applied Microbiology and Biotechnology (2021)
-
Digital technologies in the public-health response to COVID-19
Nature Medicine (2020)